Literature DB >> 24656637

The effect of strut allograft and its position on Vancouver type B1 periprosthetic femoral fractures: a biomechanical study.

Kerim Sariyilmaz1, Fatih Dikici1, Goksel Dikmen1, Ergun Bozdag2, Emin Sunbuloglu2, Bugra Bekler2, Onder Yazicioglu1.   

Abstract

The aim of this study is to assess the biomechanical advantage of adding strut allograft and the effect of its position on the construct in Vancouver type B1 fractures. Fifteen forth-generation synthetic femurs were used and created a fracture model at the tip of prosthesis, and subsequently fixated with a lateral plate only, lateral plate and medial strut, lateral plate and anterior strut. Rotational and axial tests were performed. In all loading tests, the plate with medial strut group was stiffer than the other constructs and had higher failure load values and had less displacement in the fracture site. A combination of a plate with a medial strut allograft provides more mechanical stability on periprosthetic femoral fractures near the tip of a total hip arthroplasty.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Vancouver type B1; biomechanical; periprosthetic; strut allograft

Mesh:

Year:  2014        PMID: 24656637     DOI: 10.1016/j.arth.2014.02.017

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  High union rates of locking compression plating with cortical strut allograft for type B1 periprosthetic femoral fractures.

Authors:  Ingwon Yeo; Kee-Hyung Rhyu; Sang-Min Kim; Yoon-Soo Park; Seung-Jae Lim
Journal:  Int Orthop       Date:  2016-01-13       Impact factor: 3.075

2.  Association of the Anterolateral Thigh Osteomyocutaneous Flap With Femur Structural Integrity and Assessment of Prophylactic Fixation.

Authors:  Mitchell L Worley; Travis M Patterson; Evan M Graboyes; Yongren Wu; Robert M Brody; Joshua Hornig; Zeke Walton
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-09-01       Impact factor: 6.223

Review 3.  The management of type B1 periprosthetic femoral fractures: when to fix and when to revise.

Authors:  Adam T Yasen; Fares S Haddad
Journal:  Int Orthop       Date:  2014-12-16       Impact factor: 3.075

4.  Strut Onlay Allograft in Revision Arthroplasty: Osseous Union and Clinical Outcome.

Authors:  Dietmar Dammerer; Alexander Wurm; Clemens Frischhut; Johannes Petersen; Miar Ouaret; Michael Liebensteiner
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 5.  Biomechanical Concepts for Fracture Fixation.

Authors:  Michael Bottlang; Christine E Schemitsch; Aaron Nauth; Milton Routt; Kenneth A Egol; Gillian E Cook; Emil H Schemitsch
Journal:  J Orthop Trauma       Date:  2015-12       Impact factor: 2.512

6.  A methodology for the generation and non-destructive characterisation of transverse fractures in long bones.

Authors:  Fernando Y Zapata-Cornelio; Zhongmin Jin; David C Barton; Alison C Jones; Ruth K Wilcox
Journal:  Bone Rep       Date:  2018-04-25

7.  Combined Surgical and Medical Treatment for Vancouver B1 and C Periprosthetic Femoral Fractures: A Proposal of a Therapeutic Algorithm While Retaining the Original Stable Stem.

Authors:  Nicola Mondanelli; Elisa Troiano; Andrea Facchini; Martina Cesari; Giovanni Battista Colasanti; Vanna Bottai; Francesco Muratori; Carla Caffarelli; Stefano Gonnelli; Stefano Giannotti
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-12-21

8.  A New System for Periprosthetic Fracture Stabilization-A Biomechanical Comparison.

Authors:  Daniel Rau; Gabriele Rußow; Mark Heyland; Dag Wulsten; Clemens Kösters; Werner Schmölz; Sven Märdian
Journal:  J Clin Med       Date:  2022-02-08       Impact factor: 4.241

9.  Bone restoration after revision hip arthroplasty with femoral bone defects using extensively porous-coated stems with cortical strut allografts.

Authors:  Zichuan Ding; Tingxian Ling; Ping Mou; Duan Wang; Kai Zhou; Zongke Zhou
Journal:  J Orthop Surg Res       Date:  2020-05-27       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.